{"DataElement":{"publicId":"2771911","version":"1","preferredName":"Donor Cellular Infusion Source Isolation From Whole Blood Unit Blood Component Tranfusion Unit Number","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation._Where something is available or from where it originates._A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements._Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument._Blood that has not been separated into its various components; blood that has not been modified except for the addition of an anticoagulant._A single undivided thing occurring in the composition of something else._Number of blood component units transfused into a person.","longName":"DCI_S_I_F_WBU_T_U_CT","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2771898","version":"1","preferredName":"Donor Cellular Infusion Source Isolation From Whole Blood Unit","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation._Where something is available or from where it originates._A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements._Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument._Blood that has not been separated into its various components; blood that has not been modified except for the addition of an anticoagulant._A single undivided thing occurring in the composition of something else.","longName":"DCI_SRC_ISO_FR_WB_UN","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2793802","version":"1","preferredName":"Donor Cellular Infusion Source","preferredDefinition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.:Source; where something is available.","longName":"C77273:C25683","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Donor Cellular Infusion","conceptCode":"C77273","definition":"A form of adoptive immunotherapy used after hematopoietic stem cell transplantation (HSCT). Lymphocytes from the original stem cell donor are given to the HSCT recipient, after the transplant, to augment an antitumor immune response (graft-versus-tumor), or ensure that the donor stem cells remain engrafted. Although lymphocytes are the most commonly used cell, other cells including fibroblasts, mesenchymal or dendritic cells may be delivered to affect chimerism, treat Graft vs. Host Disease, treat viral infections or Post Transplant Lymphoproliferative Disease or other novel uses under investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Source","conceptCode":"C25683","definition":"Where something is available or from where it originates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5939575B-8502-4678-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-14","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-14","modifiedBy":"ONEDATA","dateModified":"2008-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2771896","version":"1","preferredName":"Isolated From Whole Blood Unit","preferredDefinition":"Marked by separation of or from usually contiguous elements.:Used to indicate a specified place or time as a starting point.:Blood that has not been separated into its various components; blood that has not been modified except for the addition of an anticoagulant.:Any division of quantity accepted as a standard of measurement or exchange.","longName":"C25549:C25516:C41067:C44278","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Isolation","conceptCode":"C25549","definition":"A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"From","conceptCode":"C25516","definition":"Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Whole Blood","conceptCode":"C41067","definition":"Blood that has not been separated into its various components; blood that has not been modified except for the addition of an anticoagulant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unit","conceptCode":"C44278","definition":"A single undivided thing occurring in the composition of something else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"543394A3-85E3-5AEC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-11","modifiedBy":"ONEDATA","dateModified":"2008-08-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"543394A3-85F4-5AEC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182864","version":"1","preferredName":"Blood Component Tranfusion Unit Number","preferredDefinition":"Number of blood component units transfused into a person.","longName":"BLD_TRNSF_UNIT_NUM","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177868","version":"1","preferredName":"Number","preferredDefinition":"a concept of quantity derived from zero and units.","longName":"Number","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CA35863A-4B1D-728A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-10-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-10-22","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D751C8E1-8489-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-09","modifiedBy":"REEVESD","dateModified":"2005-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"dci_src_whole_bld_units","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedSubstanceAdministration:productDose","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify number of units:","type":"Alternate Question Text","description":"Specify number of units:","url":null,"context":"NHLBI"},{"name":"Specify the number of isolate","type":"Preferred Question Text","description":"Specify the number of isolated units of whole blood:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2771911","type":"BRIDG Mapping Path","description":"PerformedSubstanceAdministration.productDose WHERE PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Adminsiter donor cellular infusion(DCI)\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5433B6F6-4FED-6026-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-11","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}